Riskpilot← Back to searchSign inGet full accessHierta Vårdcentral Vilbergen AB
ABActiveOrg 5592654916Urbergsgatan 90General medical practice activities · NACE 8621Est. 202036 employees
Revenue 2024
SEK 47,5M
+11% vs 2023
EBITDA margin
5.8%
+2% vs 2023
Equity ratio
19.7%
Financial strength
Net profit 2024
SEK 108K
+2191% vs 2023
| Revenue | SEK 47,5M | +11% |
| EBITDA | SEK 2,8M | +2% |
| Net profit | SEK 108K | +2191% |
| Total assets | SEK 6,7M | +9% |
| Equity | SEK 1,3M | +9% |
| Employees | 36 | — |
Legal name
Hierta Vårdcentral Vilbergen AB
Org number
5592654916
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
31 juli 2020
Share capital
SEK 25 000
Employees
36 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Driva vårdcentral
Address
Urbergsgatan 90
Phone
+4611215600
Email
erik_lindh@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 30 433 | 38 471 | 42 585 | 47 460 |
| Staff expenses | — | −23 611 | −25 622 | −31 592 |
| EBITDA | −1 072 | 1 836 | 2 711 | 2 758 |
| Depreciation & amort. | −112 | −79 | −79 | −97 |
| EBIT | −1 184 | 1 758 | 2 632 | 2 661 |
| Net financials | −1 | −1 | −5 | −8 |
| Profit before tax | −1 185 | 1 157 | 13 | 153 |
| Tax | −0 | −0 | −8 | −45 |
| Net profit | −1 185 | 1 157 | 5 | 108 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 5 962 | 6 233 | 6 123 | 6 660 |
| Equity | 40 | 1 196 | 1 201 | 1 309 |
| Long-term debt | 60 | 60 | 0 | — |
| Short-term debt | 5 862 | 4 977 | 4 922 | 5 351 |
| Total debt | 5 922 | 5 037 | 4 922 | 5 351 |
EBITDA margin
5.8%
This company
15.8%
Market median
-63% vs market
20212024
Equity ratio
19.7%
This company
38.2%
Market median
-48% vs market
20212024
Return on equity
8.3%
This company
18.4%
Market median
-55% vs market
20212024
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20212024
Asset turnover
7.13×
This company
1.12×
Market median
+537% vs market
20212024
Debt / equity
4.09×
This company
0.62×
Market median
-560% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
VH Chief Auditor | Chief Auditor | 2025 |
EA Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
JH Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Former (2) | ||
| Chairman | 2020 – 2024 | |
| Chairman | 2023 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medinvest Nord AB
Hierta Vårdcentral Vilbergen AB Board members of Hierta Vårdcentral Vilbergen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Viktor Hans Erik Jessen Sjöström | Chief Auditor | 0 companies |
| Josef Hagsten | Chief Auditor | 0 companies |
| Eva Alexandra Nistal | Chief Executive Officer | 0 companies |
| André N J D C Skagervik | Chairman | 0 companies |
| Magnus Lind | Chairman | 0 companies |
| Erik Karl Johan Lind | Board of Directors | 0 companies |
| Karin Anna Maria Lind | Chairman | 0 companies |